Related Experiment Video
Updated: Jun 3, 2025

06:05
Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration
Published on: July 14, 2023
936
In Vitro Engineered ECM-incorporated Hydrogels for Osteochondral Tissue Repair: A Cell-Free Approach
Ali Coyle1, Aishik Chakraborty2,3, Jiaqi Huang2
1School of Biomedical Engineering, The University of Western Ontario, London, ON, N6A 5B9, Canada.
Advanced Healthcare Materials
|January 6, 2025
Summary
A new 3D printable hydrogel platform uses decellularized extracellular matrix (dECM) to repair bone and cartilage. This innovative scaffold offers a cell-free therapeutic strategy for osteoarthritis management.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Tissue Engineering
Background:
- Osteoarthritis prevalence is rising in aging populations, demanding advanced biomedical treatments.
- Current treatments like grafts and drug-loaded scaffolds have limitations, including poor drug half-life and off-target effects.
- There is a need for improved therapeutic strategies for bone and cartilage repair.
Purpose of the Study:
- To develop a 3D printable, robust hydrogel-based tissue-repair platform.
- To incorporate decellularized extracellular matrix (dECM) from differentiated cells as therapeutic cargo.
- To create a bioactive osteochondral plug for potential osteoarthritis management.
Main Methods:
- Murine pre-osteoblastic and pre-chondrogenic cells were differentiated in vitro, decellularized, and incorporated into methacrylated gelatin (GelMA).
- Osteogenic (GelO) and chondrogenic (GelC) hydrogels were formed.
- A carbodiimide coupling reaction was used to covalently adhere GelO and GelC, creating a multi-layered hydrogel.
Main Results:
- The developed GelO and GelC hydrogels successfully induced differentiation of human adipose-derived stem cells (hASCs) toward osteogenic and chondrogenic lineages.
- The multi-layered hydrogel demonstrated potential as a bioactive osteochondral plug.
- The designed hydrogel platform showed efficacy in inducing hASC differentiation in vitro.
Conclusions:
- The bioactive dECM-carrying 3D printed hydrogel represents a promising new therapeutic strategy.
- This cell-free approach offers potential for bone and cartilage repair.
- The developed platform holds promise for future osteoarthritis management.

